Dr. Marcelle Tuttle, a first-year fellow in the Tufts Medical Center Division of Nephrology, will be working on research that focuses on the development of pulmonary hypertension in patients with chronic kidney disease (CKD).
Tufts Medicine, a leading Massachusetts integrated, academic health system and Acadia Healthcare Company, the largest standalone provider of behavioral health services in the U.S., today held a ceremony to celebrate the start of construction on its previously announced state-of-the-art, 144-bed behavioral health hospital in Malden, Massachusetts.
Targeted genome sequencing found to deliver routine results more quickly and at a lower cost; lack of standardization in analytic techniques remains a barrier to diagnosis and medical care for genetic disorders in the first year of life.
Dozens of volunteers, hospital administrators and staff, representatives from the Greater Boston Food Pantry recently gathered to celebrate the 10th anniversary of MelroseWakefield Hospital’s Mobile Food Market.
Tufts Clinical and Translational Science Institute (CTSI) has received a $78.4 million Clinical and Translational Science Award from the NIH, the fourth consecutive grant since its founding in 2008.
Brent P. Forester, MD, MSc. joined the Tufts Medicine family as Psychiatrist-in-Chief and Chairman for the Department of Psychiatry at Tufts Medical Center, Director of Behavioral Health for Tufts Medicine and Professor of Psychiatry and the Dr. Francis S. Arkin Chair of Psychiatry at Tufts University School of Medicine.
Tufts Medicine announced today that Perrie O'Tierney-Ginn, PhD, has been named the permanent Executive Director of the Mother Infant Research Institute (MIRI) at Tufts Medical Center. She had served as the Interim Executive Director of MIRI since September 2021.
A comprehensive review study has found that Medicaid and commercial insurance coverage policies for Biogen Alzheimer’s disease drug, Aduhelm, showed large inconsistencies based on plan and geography.